$CATX
Perspective Therapeutics Inc

2021 Q4 Form 10-Q Financial Statement

#000143774922002803 Filed on February 09, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $2.816M $2.359M
YoY Change 19.37% 6.94%
Cost Of Revenue $1.596M $1.192M
YoY Change 33.89% 8.86%
Gross Profit $1.220M $1.167M
YoY Change 4.54% 5.04%
Gross Profit Margin 43.32% 49.47%
Selling, General & Admin $2.320M $1.748M
YoY Change 32.72% 0.63%
% of Gross Profit 190.16% 149.79%
Research & Development $535.0K $285.0K
YoY Change 87.72% 2.89%
% of Gross Profit 43.85% 24.42%
Depreciation & Amortization $71.00K $46.00K
YoY Change 54.35% -4.17%
% of Gross Profit 5.82% 3.94%
Operating Expenses $2.855M $2.040M
YoY Change 39.95% 1.29%
Operating Profit -$1.635M -$873.0K
YoY Change 87.29% -3.32%
Interest Expense $31.00K $5.000K
YoY Change 520.0% -16.67%
% of Operating Profit
Other Income/Expense, Net $31.00K $5.000K
YoY Change 520.0% -16.67%
Pretax Income -$1.604M -$868.0K
YoY Change 84.79% -3.23%
Income Tax
% Of Pretax Income
Net Earnings -$1.604M -$868.0K
YoY Change 84.79% -3.23%
Net Earnings / Revenue -56.96% -36.8%
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$11.30K -$10.45K
COMMON SHARES
Basic Shares Outstanding 141.9M 83.05M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.35M $9.585M
YoY Change 529.67% 201.42%
Cash & Equivalents $60.35M $9.585M
Short-Term Investments
Other Short-Term Assets $535.0K $301.0K
YoY Change 77.74% -39.44%
Inventory $1.068M $665.0K
Prepaid Expenses
Receivables $1.647M $1.738M
Other Receivables $0.00 $0.00
Total Short-Term Assets $63.60M $12.29M
YoY Change 417.57% 118.24%
LONG-TERM ASSETS
Property, Plant & Equipment $1.973M $1.830M
YoY Change 7.81% 5.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $110.0K $119.0K
YoY Change -7.56% -16.2%
Total Long-Term Assets $3.648M $3.224M
YoY Change 13.15% -2.36%
TOTAL ASSETS
Total Short-Term Assets $63.60M $12.29M
Total Long-Term Assets $3.648M $3.224M
Total Assets $67.25M $15.51M
YoY Change 333.52% 73.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $847.0K $500.0K
YoY Change 69.4% -20.89%
Accrued Expenses $998.0K $841.0K
YoY Change 18.67% 18.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.845M $1.335M
YoY Change 38.2% -0.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.016M $1.405M
YoY Change -27.69% -3.24%
Total Long-Term Liabilities $1.016M $1.405M
YoY Change -27.69% -3.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.845M $1.335M
Total Long-Term Liabilities $1.016M $1.405M
Total Liabilities $2.861M $2.740M
YoY Change 4.42% -1.86%
SHAREHOLDERS EQUITY
Retained Earnings -$95.17M -$89.52M
YoY Change 6.31% 3.84%
Common Stock $159.6M $102.3M
YoY Change 55.99% 10.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $64.39M $12.77M
YoY Change
Total Liabilities & Shareholders Equity $67.25M $15.51M
YoY Change 333.52% 73.66%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income -$1.604M -$868.0K
YoY Change 84.79% -3.23%
Depreciation, Depletion And Amortization $71.00K $46.00K
YoY Change 54.35% -4.17%
Cash From Operating Activities -$1.313M -$760.0K
YoY Change 72.76% -40.53%
INVESTING ACTIVITIES
Capital Expenditures -$81.00K -$60.00K
YoY Change 35.0% -43.4%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$81.00K -$60.00K
YoY Change 35.0% -43.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.500M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 56.00K 8.465M
YoY Change -99.34% -77054.55%
NET CHANGE
Cash From Operating Activities -1.313M -760.0K
Cash From Investing Activities -81.00K -60.00K
Cash From Financing Activities 56.00K 8.465M
Net Change In Cash -1.338M 7.645M
YoY Change -117.5% -648.03%
FREE CASH FLOW
Cash From Operating Activities -$1.313M -$760.0K
Capital Expenditures -$81.00K -$60.00K
Free Cash Flow -$1.232M -$700.0K
YoY Change 76.0% -40.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
146000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292000 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
142040266
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142040266
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142040266
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141915266
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141915266
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M15D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.72
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.72
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.68
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60354000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63828000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1647000 USD
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
2013000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1068000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
980000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
535000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
481000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
63604000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
67302000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1973000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1958000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
642000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
768000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
741000 USD
CY2021Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
76000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
110000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
130000 USD
CY2021Q4 us-gaap Assets
Assets
67252000 USD
CY2021Q2 us-gaap Assets
Assets
70416000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
847000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
730000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
260000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
252000 USD
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
153000 USD
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
98000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
103000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
100000 USD
CY2021Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
608000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
2861000 USD
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
624000 USD
CY2021Q4 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
223000 USD
CY2021Q2 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
362000 USD
CY2021Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
259000 USD
CY2021Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
259000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1845000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1801000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
392000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
524000 USD
CY2021Q4 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
0 USD
CY2021Q2 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
77000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
3010000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
142000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
142000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
159421000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158589000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95172000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91325000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
64391000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
67406000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2816000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2359000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5380000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4743000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1596000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1192000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3131000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2330000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
1220000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
1167000 USD
us-gaap Gross Profit
GrossProfit
2249000 USD
us-gaap Gross Profit
GrossProfit
2413000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
535000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
285000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1237000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
597000 USD
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
702000 USD
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
619000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1463000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1200000 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1618000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1129000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3458000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2196000 USD
CY2021Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-7000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-7000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
2855000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
2040000 USD
us-gaap Operating Expenses
OperatingExpenses
6158000 USD
us-gaap Operating Expenses
OperatingExpenses
4000000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1635000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-873000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3909000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1587000 USD
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000 USD
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
62000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
31000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
62000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1604000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-868000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3847000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
CY2021Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
CY2020Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000 USD
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1604000 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-868000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3847000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1584000 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Adjustment For Amortization
AdjustmentForAmortization
21000 USD
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
141955000
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
83047000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
141935000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75972000
us-gaap Net Income Loss
NetIncomeLoss
-3847000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
us-gaap Depreciation
Depreciation
119000 USD
us-gaap Depreciation
Depreciation
71000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
19000 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
16000 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
16000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
776000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
166000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-366000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-306000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
753000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
54000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-125000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
117000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-158000 USD
isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
55000 USD
isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
31000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7000 USD
isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
-216000 USD
isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
-36000 USD
isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
0 USD
isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
14000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3397000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1098000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
135000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
173000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-135000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-173000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
-0 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
9000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8471000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
56000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-868000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
12773000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
67406000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8465000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3476000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7194000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
64010000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2573000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60534000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9767000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60354000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9585000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60536000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9767000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5723000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-713000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5095000 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8471000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
596000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2243000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
65759000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
180000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1604000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
64391000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7367000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9914000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20497000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
751000 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
645000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
288000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
286000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
49000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1068000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
980000 USD
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
741000 USD
CY2021Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
76000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9340000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9206000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7248000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1973000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1958000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
3064100
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
40000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.99 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.83 pure
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
180000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
776000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
166000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1433000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7268000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
264000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
702000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2021Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M13D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7268000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10M13D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4060000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y9M
CY2020Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6250
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
112500
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q4 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
51000 USD
CY2020Q4 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
22000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23725
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
625
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6250
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3064100
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
1763000 USD
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
18000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
29500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
156225
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3125
CY2021Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
79000 USD
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
76000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
156000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
152000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
50000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
652000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
260000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
392000 USD

Files In Submission

Name View Source Status
0001437749-22-002803-index-headers.html Edgar Link pending
0001437749-22-002803-index.html Edgar Link pending
0001437749-22-002803.txt Edgar Link pending
0001437749-22-002803-xbrl.zip Edgar Link pending
ex_327647.htm Edgar Link pending
ex_327648.htm Edgar Link pending
ex_327649.htm Edgar Link pending
ex_327650.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20211231.xsd Edgar Link pending
isr-20211231_cal.xml Edgar Link unprocessable
isr-20211231_def.xml Edgar Link unprocessable
isr-20211231_lab.xml Edgar Link unprocessable
isr-20211231_pre.xml Edgar Link unprocessable
isr20211231_10q.htm Edgar Link pending
isr20211231_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending